ClinicalTrials.gov
ClinicalTrials.gov Menu

Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00250757
Recruitment Status : Terminated (Study was not renewed timely with IRB of record.)
First Posted : November 8, 2005
Last Update Posted : January 8, 2016
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance

Brief Summary:
To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.

Condition or disease
Prostate Cancer

Detailed Description:
Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions
Study Start Date : October 2005
Actual Primary Completion Date : April 2012
Actual Study Completion Date : April 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Prostate Cancer




Biospecimen Retention:   Samples Without DNA
Semen samples or Prostatic secretions (via prostate massage).


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Males with and without Prostate cancer.
Criteria

Inclusion Criteria:

  • Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Exclusion Criteria:

  • Not sepcified.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00250757


Locations
United States, New Mexico
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States, 87106
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Laurel Sillerud, MD University of New Mexico

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00250757     History of Changes
Other Study ID Numbers: 2904C
First Posted: November 8, 2005    Key Record Dates
Last Update Posted: January 8, 2016
Last Verified: January 2016

Keywords provided by New Mexico Cancer Care Alliance:
prostate
NMR Spectroscopy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases